KEVIN C TANG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN C TANG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN C TANG. KEVIN C TANG is Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Director in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and 10% Owner in Aptevo Therapeutics Inc. ($APVO) and Chief Executive Officer in Odonate Therapeutics, Inc. ($ODT).
Latest Insider Trading Transactions of KEVIN C TANG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APVO, CYCC, HRTX, LJPC, ODT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 4.53 | 30,000 | 135,900 | 30,000 | |
| Dec 23 2020 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.71 | 75,784 | 1,190,415 | 15,514,566 | 15.4 M to 15.5 M (+0.49 %) |
| Dec 23 2020 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.43 | 63,354 | 977,438 | 15,438,782 | 15.4 M to 15.4 M (+0.41 %) |
| Dec 23 2020 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.17 | 36,646 | 555,821 | 15,375,428 | 15.3 M to 15.4 M (+0.24 %) |
| Dec 23 2020 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.58 | 37,856 | 551,766 | 15,338,782 | 15.3 M to 15.3 M (+0.25 %) |
| Dec 23 2020 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.58 | 62,144 | 905,767 | 15,300,926 | 15.2 M to 15.3 M (+0.41 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.87 | 2,650 | 63,256 | 1,760,000 | 1.8 M to 1.8 M (+0.15 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.48 | 107,901 | 2,533,515 | 1,757,350 | 1.6 M to 1.8 M (+6.54 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 22.33 | 29,682 | 662,799 | 1,649,449 | 1.6 M to 1.6 M (+1.83 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.63 | 34,044 | 702,328 | 1,619,767 | 1.6 M to 1.6 M (+2.15 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.94 | 8,482 | 177,613 | 1,585,723 | 1.6 M to 1.6 M (+0.54 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.78 | 137,241 | 2,851,868 | 1,577,241 | 1.4 M to 1.6 M (+9.53 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.79 | 171,626 | 4,082,983 | 1,440,000 | 1.3 M to 1.4 M (+13.53 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 15.32 | 71,241 | 1,091,412 | 1,268,374 | 1.2 M to 1.3 M (+5.95 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 14.22 | 77,133 | 1,096,831 | 1,197,133 | 1.1 M to 1.2 M (+6.89 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 15.31 | 160,000 | 2,449,600 | 1,120,000 | 960 K to 1.1 M (+16.67 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 16.84 | 160,000 | 2,694,400 | 960,000 | 800 K to 960 K (+20.00 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 16.33 | 60,146 | 982,184 | 800,000 | 739.9 K to 800 K (+8.13 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.65 | 99,854 | 1,363,007 | 739,854 | 640 K to 739.9 K (+15.60 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.83 | 160,000 | 2,212,800 | 640,000 | 480 K to 640 K (+33.33 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.11 | 88,379 | 1,158,649 | 480,000 | 391.6 K to 480 K (+22.57 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 10.63 | 68,296 | 725,986 | 391,621 | 323.3 K to 391.6 K (+21.12 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.87 | 2,650 | 63,256 | 1,760,000 | 1.8 M to 1.8 M (+0.15 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.48 | 107,901 | 2,533,515 | 1,757,350 | 1.6 M to 1.8 M (+6.54 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 22.33 | 29,682 | 662,799 | 1,649,449 | 1.6 M to 1.6 M (+1.83 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.63 | 34,044 | 702,328 | 1,619,767 | 1.6 M to 1.6 M (+2.15 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.94 | 8,482 | 177,613 | 1,585,723 | 1.6 M to 1.6 M (+0.54 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.78 | 137,241 | 2,851,868 | 1,577,241 | 1.4 M to 1.6 M (+9.53 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.79 | 171,626 | 4,082,983 | 1,440,000 | 1.3 M to 1.4 M (+13.53 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 15.32 | 71,241 | 1,091,412 | 1,268,374 | 1.2 M to 1.3 M (+5.95 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 14.22 | 77,133 | 1,096,831 | 1,197,133 | 1.1 M to 1.2 M (+6.89 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 15.31 | 160,000 | 2,449,600 | 1,120,000 | 960 K to 1.1 M (+16.67 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 16.84 | 160,000 | 2,694,400 | 960,000 | 800 K to 960 K (+20.00 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 16.33 | 60,146 | 982,184 | 800,000 | 739.9 K to 800 K (+8.13 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.65 | 99,854 | 1,363,007 | 739,854 | 640 K to 739.9 K (+15.60 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.83 | 160,000 | 2,212,800 | 640,000 | 480 K to 640 K (+33.33 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.11 | 88,379 | 1,158,649 | 480,000 | 391.6 K to 480 K (+22.57 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 10.63 | 68,296 | 725,986 | 391,621 | 323.3 K to 391.6 K (+21.12 %) |
| Sep 30 2020 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 13.85 | 10,882 | 150,698 | 15,238,782 | 15.2 M to 15.2 M (+0.07 %) |
| Sep 30 2020 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 13.06 | 100,000 | 1,305,710 | 15,227,900 | 15.1 M to 15.2 M (+0.66 %) |
| Sep 09 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.03 | 78,369 | 316,047 | 9,405,490 | 9.3 M to 9.4 M (+0.84 %) |
| Sep 09 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.01 | 48,296 | 193,894 | 9,327,121 | 9.3 M to 9.3 M (+0.52 %) |
| Sep 09 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 3.90 | 84,152 | 328,529 | 9,278,825 | 9.2 M to 9.3 M (+0.92 %) |
| Sep 09 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 3.82 | 67,552 | 258,359 | 9,194,673 | 9.1 M to 9.2 M (+0.74 %) |
| Sep 01 2020 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.25 | 1,052,631 | 14,999,992 | 15,127,900 | 14.1 M to 15.1 M (+7.48 %) |
| Jun 04 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.94 | 215,812 | 1,065,636 | 8,695,474 | 8.5 M to 8.7 M (+2.55 %) |
| Jun 04 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.90 | 145,764 | 714,783 | 8,479,662 | 8.3 M to 8.5 M (+1.75 %) |
| Jun 04 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.88 | 253,553 | 1,237,060 | 8,333,898 | 8.1 M to 8.3 M (+3.14 %) |
| Feb 03 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.80 | 75,003 | 509,833 | 8,080,345 | 8 M to 8.1 M (+0.94 %) |
| Feb 03 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.75 | 13,292 | 89,705 | 8,005,342 | 8 M to 8 M (+0.17 %) |
| Feb 03 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.72 | 81,475 | 547,431 | 7,992,050 | 7.9 M to 8 M (+1.03 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.66 | 1,253,878 | 8,351,580 | 7,910,575 | 6.7 M to 7.9 M (+18.84 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.70 | 717,804 | 4,090,909 | 6,656,697 | 5.9 M to 6.7 M (+12.09 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.27 | 400,339 | 2,111,748 | 5,938,893 | 5.5 M to 5.9 M (+7.23 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.80 | 599,661 | 2,880,232 | 5,538,554 | 4.9 M to 5.5 M (+12.14 %) |
| Dec 23 2019 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 25.02 | 17,000 | 425,340 | 17,000 | |
| Oct 07 2019 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 17.50 | 285,714 | 4,999,995 | 5,799,810 | 5.5 M to 5.8 M (+5.18 %) |
| Jun 28 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 26.00 | 769,231 | 20,000,006 | 14,075,269 | 13.3 M to 14.1 M (+5.78 %) |
| Jun 18 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 26.89 | 21,350 | 574,020 | 13,306,038 | 13.3 M to 13.3 M (+0.16 %) |
| Jun 18 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 26.95 | 8,137 | 219,321 | 13,284,688 | 13.3 M to 13.3 M (+0.06 %) |
| Jun 18 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 26.20 | 1,905 | 49,911 | 13,276,551 | 13.3 M to 13.3 M (+0.01 %) |
| Jun 18 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 24.95 | 18,608 | 464,294 | 13,274,646 | 13.3 M to 13.3 M (+0.14 %) |
| Jun 10 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 26.31 | 20,000 | 526,220 | 13,256,038 | 13.2 M to 13.3 M (+0.15 %) |
| Jun 10 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.95 | 8,688 | 242,844 | 13,236,038 | 13.2 M to 13.2 M (+0.07 %) |
| Jun 10 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.71 | 41,312 | 1,144,557 | 13,227,350 | 13.2 M to 13.2 M (+0.31 %) |
| Jun 10 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 27.56 | 6,308 | 173,835 | 13,186,038 | 13.2 M to 13.2 M (+0.05 %) |
| Jun 05 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 26.11 | 29,484 | 769,863 | 13,179,730 | 13.2 M to 13.2 M (+0.22 %) |
| Jun 05 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 25.14 | 9,972 | 250,678 | 13,150,246 | 13.1 M to 13.2 M (+0.08 %) |
| Jun 05 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 24.99 | 4,236 | 105,852 | 13,140,274 | 13.1 M to 13.1 M (+0.03 %) |
| Jun 05 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 24.92 | 34,714 | 864,920 | 13,136,038 | 13.1 M to 13.1 M (+0.26 %) |
| Jun 05 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 22.86 | 7,427 | 169,745 | 13,101,324 | 13.1 M to 13.1 M (+0.06 %) |
| Jun 05 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 22.16 | 7,859 | 174,159 | 13,093,897 | 13.1 M to 13.1 M (+0.06 %) |
| Mar 11 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 18.94 | 77,137 | 1,460,674 | 13,086,038 | 13 M to 13.1 M (+0.59 %) |
| Mar 11 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 18.10 | 22,863 | 413,909 | 13,008,901 | 13 M to 13 M (+0.18 %) |
| Mar 11 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 17.50 | 20,000 | 349,910 | 12,986,038 | 13 M to 13 M (+0.15 %) |
| Mar 11 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 17.15 | 964 | 16,535 | 12,966,038 | 13 M to 13 M (+0.01 %) |
| Mar 11 2019 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 16.56 | 19,036 | 315,288 | 12,965,074 | 12.9 M to 13 M (+0.15 %) |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 5.99 | 12,000 | 71,880 | 12,000 | |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.54 | 79,214 | 438,806 | 4,938,893 | 4.9 M to 4.9 M (+1.63 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.43 | 120,786 | 655,699 | 4,859,679 | 4.7 M to 4.9 M (+2.55 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.38 | 200,000 | 1,075,700 | 4,738,893 | 4.5 M to 4.7 M (+4.41 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.34 | 200,000 | 1,067,920 | 4,538,893 | 4.3 M to 4.5 M (+4.61 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.24 | 200,000 | 1,047,940 | 4,338,893 | 4.1 M to 4.3 M (+4.83 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.24 | 200,000 | 1,048,980 | 4,138,893 | 3.9 M to 4.1 M (+5.08 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.33 | 200,000 | 1,066,400 | 3,938,893 | 3.7 M to 3.9 M (+5.35 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.84 | 100,000 | 583,840 | 3,738,893 | 3.6 M to 3.7 M (+2.75 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.54 | 79,214 | 438,806 | 4,938,893 | 4.9 M to 4.9 M (+1.63 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.43 | 120,786 | 655,699 | 4,859,679 | 4.7 M to 4.9 M (+2.55 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.38 | 200,000 | 1,075,700 | 4,738,893 | 4.5 M to 4.7 M (+4.41 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.34 | 200,000 | 1,067,920 | 4,538,893 | 4.3 M to 4.5 M (+4.61 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.24 | 200,000 | 1,047,940 | 4,338,893 | 4.1 M to 4.3 M (+4.83 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.24 | 200,000 | 1,048,980 | 4,138,893 | 3.9 M to 4.1 M (+5.08 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.33 | 200,000 | 1,066,400 | 3,938,893 | 3.7 M to 3.9 M (+5.35 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.84 | 100,000 | 583,840 | 3,738,893 | 3.6 M to 3.7 M (+2.75 %) |
| Dec 31 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.00 | 3,700 | 51,792 | 12,946,038 | 12.9 M to 12.9 M (+0.03 %) |
| Dec 31 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 13.99 | 10,000 | 139,866 | 12,942,338 | 12.9 M to 12.9 M (+0.08 %) |
| Dec 31 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 13.51 | 10,000 | 135,070 | 12,932,338 | 12.9 M to 12.9 M (+0.08 %) |
| Dec 31 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 13.42 | 10,000 | 134,201 | 12,922,338 | 12.9 M to 12.9 M (+0.08 %) |
| Dec 31 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 13.35 | 10,000 | 133,469 | 12,912,338 | 12.9 M to 12.9 M (+0.08 %) |
| Dec 31 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 12.04 | 10,000 | 120,394 | 12,902,338 | 12.9 M to 12.9 M (+0.08 %) |
| Dec 31 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 12.03 | 10,000 | 120,315 | 12,892,338 | 12.9 M to 12.9 M (+0.08 %) |
| Dec 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 12.09 | 10,000 | 120,937 | 12,882,338 | 12.9 M to 12.9 M (+0.08 %) |
| Dec 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 12.34 | 10,000 | 123,384 | 12,872,338 | 12.9 M to 12.9 M (+0.08 %) |
| Dec 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 12.40 | 10,000 | 123,966 | 12,862,338 | 12.9 M to 12.9 M (+0.08 %) |
| Dec 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 13.78 | 6,500 | 89,569 | 12,852,338 | 12.8 M to 12.9 M (+0.05 %) |
| Dec 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 12.44 | 3,500 | 43,527 | 12,845,838 | 12.8 M to 12.8 M (+0.03 %) |
| Dec 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 12.27 | 10,000 | 122,731 | 12,842,338 | 12.8 M to 12.8 M (+0.08 %) |
| Dec 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 13.17 | 10,000 | 131,742 | 12,832,338 | 12.8 M to 12.8 M (+0.08 %) |
| Dec 18 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.13 | 10,000 | 141,327 | 12,822,338 | 12.8 M to 12.8 M (+0.08 %) |
| Dec 18 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.18 | 1,704 | 25,862 | 12,812,338 | 12.8 M to 12.8 M (+0.01 %) |
| Dec 18 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.85 | 8,296 | 123,230 | 12,810,634 | 12.8 M to 12.8 M (+0.06 %) |
| Dec 18 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.20 | 450 | 6,840 | 12,802,338 | 12.8 M to 12.8 M (0.00 %) |
| Dec 18 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.51 | 9,550 | 138,542 | 12,801,888 | 12.8 M to 12.8 M (+0.07 %) |
| Dec 18 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.08 | 10,000 | 150,838 | 12,792,338 | 12.8 M to 12.8 M (+0.08 %) |
| Dec 18 2018 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 24.97 | 17,000 | 424,490 | 17,000 | |
| Dec 13 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.77 | 10,000 | 157,728 | 12,782,338 | 12.8 M to 12.8 M (+0.08 %) |
| Dec 13 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.65 | 4,550 | 71,218 | 12,772,338 | 12.8 M to 12.8 M (+0.04 %) |
| Dec 13 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.25 | 5,450 | 83,128 | 12,767,788 | 12.8 M to 12.8 M (+0.04 %) |
| Dec 13 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.77 | 10,000 | 157,728 | 12,782,338 | 12.8 M to 12.8 M (+0.08 %) |
| Dec 13 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.65 | 4,550 | 71,218 | 12,772,338 | 12.8 M to 12.8 M (+0.04 %) |
| Dec 13 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.25 | 5,450 | 83,128 | 12,767,788 | 12.8 M to 12.8 M (+0.04 %) |
| Dec 10 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.98 | 9,500 | 142,291 | 12,762,338 | 12.8 M to 12.8 M (+0.07 %) |
| Dec 10 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.66 | 500 | 7,330 | 12,752,838 | 12.8 M to 12.8 M (0.00 %) |
| Dec 10 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.62 | 10,000 | 146,243 | 12,752,338 | 12.7 M to 12.8 M (+0.08 %) |
| Nov 29 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.64 | 3,063 | 47,912 | 12,742,338 | 12.7 M to 12.7 M (+0.02 %) |
| Nov 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.43 | 6,937 | 107,046 | 12,739,275 | 12.7 M to 12.7 M (+0.05 %) |
| Nov 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.43 | 6,937 | 107,046 | 12,739,275 | 12.7 M to 12.7 M (+0.05 %) |
| Nov 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.25 | 4,644 | 70,830 | 12,732,338 | 12.7 M to 12.7 M (+0.04 %) |
| Nov 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.25 | 4,644 | 70,830 | 12,732,338 | 12.7 M to 12.7 M (+0.04 %) |
| Nov 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.15 | 5,356 | 81,141 | 12,727,694 | 12.7 M to 12.7 M (+0.04 %) |
| Nov 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.15 | 5,356 | 81,141 | 12,727,694 | 12.7 M to 12.7 M (+0.04 %) |
| Nov 05 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.87 | 10,000 | 148,727 | 12,722,338 | 12.7 M to 12.7 M (+0.08 %) |
| Oct 30 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.96 | 10,000 | 149,642 | 12,712,338 | 12.7 M to 12.7 M (+0.08 %) |
| Oct 30 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.85 | 235 | 3,725 | 12,702,338 | 12.7 M to 12.7 M (0.00 %) |
| Oct 25 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.78 | 9,765 | 154,059 | 12,702,103 | 12.7 M to 12.7 M (+0.08 %) |
| Oct 25 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 14.69 | 10,000 | 146,904 | 12,692,338 | 12.7 M to 12.7 M (+0.08 %) |
| Oct 25 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.61 | 3,313 | 51,728 | 12,682,338 | 12.7 M to 12.7 M (+0.03 %) |
| Oct 25 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.42 | 6,687 | 103,130 | 12,679,025 | 12.7 M to 12.7 M (+0.05 %) |
| Oct 25 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 15.45 | 10,000 | 154,479 | 12,672,338 | 12.7 M to 12.7 M (+0.08 %) |
| Oct 01 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.33 | 20,000 | 386,644 | 12,662,338 | 12.6 M to 12.7 M (+0.16 %) |
| Oct 01 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.17 | 10,000 | 191,722 | 12,642,338 | 12.6 M to 12.6 M (+0.08 %) |
| Oct 01 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 18.95 | 3,801 | 72,012 | 12,632,338 | 12.6 M to 12.6 M (+0.03 %) |
| Oct 01 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 18.70 | 6,199 | 115,929 | 12,628,537 | 12.6 M to 12.6 M (+0.05 %) |
| Sep 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.07 | 10,000 | 190,664 | 12,622,338 | 12.6 M to 12.6 M (+0.08 %) |
| Sep 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.65 | 10,000 | 196,477 | 12,612,338 | 12.6 M to 12.6 M (+0.08 %) |
| Sep 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 19.98 | 10,000 | 199,839 | 12,602,338 | 12.6 M to 12.6 M (+0.08 %) |
| Sep 26 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 20.30 | 10,000 | 202,993 | 12,592,338 | 12.6 M to 12.6 M (+0.08 %) |
| Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 20.43 | 10,000 | 204,267 | 12,582,338 | 12.6 M to 12.6 M (+0.08 %) |
| Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 20.43 | 10,000 | 204,267 | 12,582,338 | 12.6 M to 12.6 M (+0.08 %) |
| Sep 20 2018 | ODT | Odonate Therapeuti ... | TANG KEVIN C | Chief Executive Off ... | Buy | P | 20.08 | 10,000 | 200,788 | 12,572,338 | 12.6 M to 12.6 M (+0.08 %) |